A combination treatment may improve survival in patients with both pulmonary hypertension and pulmonary fibrosis, a study ...

Synhale has acquired telaglenastat, and is planning a Phase 2 clinical trial testing the therapy in patients with pulmonary ...

Reducing the levels of the protein NEK2 in the pulmonary arteries may reverse vascular remodeling in PAH, a rat study showed.

There are night owls and morning larks, writes columnist Colleen Steele, referring to people's sleep habits. So which bird are you?